Division of Surgical Oncology & Endocrine Surgery

The Division has an extensive basic research program that emphasizes molecular biology and conducts department-sponsored and federally sponsored research in several areas. The basic science research programs of each faculty member are as follows:

• R. Daniel Beauchamp, MD:
  TGF-beta and Ras signaling in colon cancer, mouse models of colon cancer.
• Mark C. Kelley, MD:
  Dendritic cell immunotherapy for melanoma, growth factor signaling and molecular targeted therapy for melanoma.
• A. Scott Pearson, MD:
  Regulation of cell adhesion and tight junctions in colon carcinogenesis.
• Nipun Merchant, MD:
  EGF signaling in colon cancer, molecular targeted therapy for colon cancer.
• Ingrid Meszoely, MD:
  DPC4 replacement gene therapy in pancreatic cancer.
• James T. Broome, MD:
  Intra-operative identification of thyroid and parathyroid tissue using optical fluorescence; surgical techniques in treatment of adrenal cortical carcinoma.
• Ana Grau, MD:
  TGF-beta and Ras signaling in breast cancer.
• Eric H. Liu, MD:
  Islet transplantation and imaging of the beta cell for diagnosis and treatment of diabetes; immunology and transplantation.